Clicky

Acumen Pharmaceuticals, Inc.(ABOS) News

ABOS price today by TradingView
Date Title
Jul 16 Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer’s Disease at the Alzheimer’s Association International Conference (AAIC) 2023
Jul 16 Acumen's Alzheimer's drug passes initial safety test